Original Article

Adverse Drug Reactions of Antiepileptic Drugs in Neurology Department of M.Y.H Indore, India: An Observational, Prospective Study

Abstract

Background: Epilepsy is the second most common neurological disorder that affects 1 percent of global population. Since antiepileptics have narrow therapeutic index having multiple adverse drug reactions (ADRs) thus have significant safety concerns. The aim of this study was to observe adverse drug reactions due to antiepileptics in neurology department M.Y.H. Indore, India.Methods: An observational prospective study was done from November 2021 to January 2022. Patients having history of seizures attending neurology outpatient department at MYH Hospital, who were on antiepileptic drugs were recruited. Suspected adverse drug reaction forms were recorded and their causality assessment was done by Naranjo’s scale. Results: Data of total 70 patients were recorded. Males reporting ADRs due to antiepileptics were 67.1% and females 32.8%. Using Naranjo’s scale, we noted 93.3% ADRs as “probable” and 6.7% as “possible”. Common causes of prescribing antiepileptic drugs were known case of epilepsy (78.5%),old case of  neurocysticercosis (11.4%),post traumatic(4.3%),gliosis (2.8%) and tuberculoma (2.8%) .Most ADRs were dermatological 76% (rashes),central nervous system (16%) (nocturnal enuresis, poor school performance, dizziness, headache, sleep disturbances, personality changes) ,Gastrointestinal (8%) (gastric irritation, nausea, vomiting and hepatotoxicity) .Most common drug for causing  ADRs were sodium valproate(58.5%),carbamazepine(17.14%),phenytoin(14.2%),leviteracetam(7.1%),and lamotrigine(2.8%). Conclusion: Our study aimed us to know the incidence and patterns of adverse drug reactions due to antiepileptics in a tertiary care institute of central India. Despite of recent advances and novel therapies used for the treatment of epilepsy, conventional drugs like sodium valproate, phenytoin and carbamazepine still are the first choice for the management and treatment of seizures and their ADRs are very common.

1. Murray CJ, Vos T, Lozano R, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380: 2197–2223.
2.Banerjee PN, Filippi D, Hauser WA. The descriptive epidemiology of epilepsy-a review. Epilepsy Res. 2009; 85(1):31–45.
3.World Health Organization (WHO). Epilepsy in the WHO African region: bridging the gap. the global campaign against epilepsy “out of the shadows.” Geneva: World Health Organization, 2004.
4.Fiest KM, Sauro KM, Wiebe S, et al. Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology. 2017; 88(3): 296–303.
5.Schlienger RG, Oh PI, Knowles SR, et al. Quantifying the costs of serious adverse drug reactions to antiepileptic drugs. Epilepsia. 1998; 39: S27–S32.
6.Anderson M, Choonara I. A systematic review of safety monitoring and drug toxicity in published randomised controlled trials of antiepileptic drugs in children over a 10-year period. Arch Dis Child. 2010; 95: 731-8.
7. Cramer JA, Mintzer S, Wheless J, et al. Adverse effects of antiepileptic drugs: a brief overview of important issues. Expert Rev Neurother. 2010; 10(6): 885–891.
8.Schmidt D. Efficacy of new antiepileptic drugs. Epilepsy Curr. 2011; 11(1): 9–11.
9. Tripathi KD. Edition:8th, Antiepileptic Drugs, page no. 438.Publisher:Jaypee brothers,Year :2019 ,reprint ISBN:9789352704996.
10.Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–4.
11. Central Drugs Standard Control Organization. Adverse Drug Reaction Reporting Form, India. Available from: http://www.cdsco.nic.in [Last accessed on 2010 Dec 22]
12. Kim HK, Kim DY, Bae EK, Kim DW. Adverse Skin Reactions with Antiepileptic Drugs Using Korea Adverse Event Reporting System Database, 2008-2017. J Korean Med Sci. 2020;35(4):e17.
13.Bansal D, Azad C, Kaur M, Rudroju N, Vepa P, Guglani V. Adverse effects of antiepileptic drugs in North Indian pediatric outpatients. Clin Neuropharmacol. 2013; 36: 107-13.

14.Kousalya K, Swathi Cherukuri DP, Padmasani LN, Arun Prasath TS. Drug utilization pattern of antiepileptics and their adverse effects in pediatrics. World J Pharmaceutical Res. 2014; 3(9): 504-13.
15.Mathur S, Sen S, Ramesh L, Kumar S. Utilization pattern of antiepileptic drugs and their adverse effects in a teaching hospital. Asian J Pharm Clin Res. 2010; 3: 55 -60.
16. George J, Kulkarni C, Sarma GRK. Antiepileptic Drugs and Quality of Life in Patients with Epilepsy: A Tertiary Care Hospital-Based Study. Value Health Reg Issues. 2015;6:1-6.
17.Mistry RA, Solanki KC, Prajapati HK, Doshi TM, Trivedi HR. Drug utilization pattern of antiseizure drugs and their adverse effects in the pediatric population, in a tertiary care hospital attached to a medical college. Int J Basic Clin Pharmacol. 2014; 3: 336-42.
18.Karimzadeh P, Bakrani V. Antiepileptic drug-related adverse reactions and factors influencing these reactions. Iran J Child Neurol. 2013; 7: 25-9.
19. Ayalew MB, Muche EA. Patient reported adverse events among epileptic patients taking antiepileptic drugs. SAGE Open Med. 2018;6:2050312118772471.
20. Kaushik S, Chopra D, Sharma S, Aneja S. Adverse Drug Reactions of Anti-Epileptic Drugs in Children with Epilepsy: A Cross-Sectional Study. Curr Drug Saf. 2019;14(3):217-224.
Files
IssueVol 11, No 1 (Winter 2023) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/jpc.v11i1.12635
Keywords
Adverse Drug Reactions; Antiepileptic Drugs; Epilepsy; Pharmacovigilance
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Hussain S, Kushwah A, Verma A, Mishra P, Sindhwani K. Adverse Drug Reactions of Antiepileptic Drugs in Neurology Department of M.Y.H Indore, India: An Observational, Prospective Study. J Pharm Care. 2023;11(1):12-15.